Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: A prospective single-arm study on the relationship between dose-volume parameters of pelvic functional bone marrow and acute hematological toxicities during intensity-modulated radiotherapy with or without concurrent chemotherapy for uterine cervical/endometrial cancer

Fig. 3

ROC curve of FBM dose-volume parameters for predicting the incidence of grade ≥ 2 HT. (1) ROC curve of FBM1 Dmax for predicting the incidence of grade ≥ 2 leukopenia (3a). (2) ROC curve of FBM2 Dmean for predicting the incidence of grade ≥ 2 thrombocytopenia (3b). (3) ROC curve of FBM1 V10 for predicting the incidence of grade ≥ 2 anemia (3c)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us